Bookmark

Add to MyYahoo RSS

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

Yesterday | AlertNet

Coke, J&J join big companies behind new employee wellness push

Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson & Johnson, unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health. The newly-formed group, called The CEO Council on Health and Innovation, said it came together "to lead the U.S. business community" in improving employee and community health and reducing costs.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Beverages, Biotech, CocaCola, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Banking, Bank of America, Financial Services

Yesterday | Seeking Alpha

Steer Clear Of Viking Therapeutics' IPO

VKTX, a clinical-stage biopharmaceutical firm developing treatments for metabolic and endocrine disorders, plans to raise $55.0 million in its upcoming IPO. Though VKTX does have a broad portfolio of product candidates, none of them are any where near the point of commercialization.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Yesterday | Seeking Alpha

Is There Further Upside In Medivation?

Although Medivation shares have already gained more than 46% this year as investors expected FDA approval for expanded use of Xtandi, there is still 20%-25% upside. The upside potential could be even more if Medivation reports encouraging results from trials to evaluate Xtandi as a front-line therapy.

Comment?

Related Topix: Startups, Medivation, Healthcare Law, Law, Prostate Cancer, Medicine, Cancer, Health, Biotech, Healthcare Industry

Mon Sep 15, 2014

Forbes.com

One Put, One Call Option To Know About for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wall Street Journal

Why Pensions Went Away: A Theory

Adam Cobb, a management professor at the University of Pennsylvania's Wharton School, suggests that shareholders have gained greater influence in firms while employees' power has waned. And in their hunt for big returns, shareholders-particularly financial investors that purchase large stakes-play an important role in the shrinking pool of pensions.

Comment?

Related Topix: Pension, Personal Finance, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Social Security

Seeking Alpha

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious

TKAI, a clinical-stage biopharmaceutical company, engaged in the development of novel treatments for prostate cancer, plans to raise $75.6 million in its upcoming IPO. Tokai Pharmaceuticals Inc , a clinical-stage biopharmaceutical company engaged in the development of novel treatments for prostate cancer, plans to raise $75.6 million in its upcoming IPO.

Comment?

Related Topix: Prostate Cancer, Health, Cambridge, MA, Biotech, Medicine, Healthcare Industry, Startups, Exelixis, Boston University

Advertising Age

Meet Ad Age's 2014 Top Digital Marketers

Bacon barters. Social-media roasts. Selfies during the Oscars. These are just some of the business-building brainstorms that transpired under the watch of our Top Digital Marketers.

Comment?

Related Topix: Marketing, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, LOC-AID Technologies

Sun Sep 14, 2014

Adweek

MasterChef Finalist Explains the Crossover Between Cooking and Advertising

When she was auditioning for Season 5 of Fox's hit cooking show MasterChef, Elizabeth Cauvel told producers she was an associate creative director at New York-based ad agency MRY, working on Johnson & Johnson brands like Listerine and Band-Aid. Their response: blank stares all around.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Johnson, NY, Startups, Television

The Daily Record

Mesh scandal: Another boost for Scottish campaigners as US victim wins A 60m payout

MARTHA Salazar's case in Dallas, Texas - the second major victory for mesh victims in America within days - prompts new calls for criminal inquiry in Scotland. Martha Salazar won the huge payout after the court in Dallas, Texas, heard that the Obtryx implant made by Boston Scientific was defective.

Comment?

Related Topix: Dallas, TX, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Seeking Alpha

Retirement Strategy: How Will Rising Interest Rates Affect Dividend Growth Investors?

While the old adage of "as interest rates rise, stocks will fall" rings true for many stocks, many others will actually do as well, if not better, in that environment. The 10-year Treasury rate "sky-rocketed" to a lofty 2.60% last week, and many interest rate stocks took it on the chin.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Exxon Mobil, Energy, Oil & Gas, Biotech, Medicine, Healthcare Industry, Restaurant Management, Mcdonalds, Chevron Corporation

Sat Sep 13, 2014

New Vision

'Profit motive big hurdle for Ebola drugs'

For nearly four decades, mention of the Ebola virus has evoked death and terror, yet a simple factor money has stood in the way of erasing the curse, experts say. Despite its evil reputation, Ebola breaks out only rarely in brief if murderous spurts in impoverished African countries.

Comment?

Related Topix: Epidemic, Natural Disasters, Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Fri Sep 12, 2014

Globe and Mail

For homemaker, investing is an integral part of household management

Shares in 35 large-cap companies diversified across 17 sectors within Canada and the United States, including Telus, Enbridge, TD, McDonald's, General Mills, Procter & Gamble and Johnson & Johnson. After homeschooling her kids for 17 years, Faye Hamm now works part time and focuses on investing the income she and her husband are putting aside for retirement.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Personal Finance, Retirement

Seeking Alpha

Medivation, Now The Deluge

In August 2012 biotech firm Medivation launched prostate cancer drug Xtandi. Since this launch XTANDI has trailed it's competitor in the anti-androgen market, Johnson & Johnson produced Zytiga, due to a more restricted label.

Comment?

Related Topix: Startups, Medivation, Medicine, Cancer, Health, Prostate Cancer, Biotech, Healthcare Industry, Scios, Healthcare Law, Law

PR-inside.com

Taiwan baby products market: Johnson & Johnson and BA1 4bchen the...

These include Johnson & Johnson, BA1 4bchen, Sebamed, Chicco and Pigeon, which together accounted for 71% of total sales in 2012. International brands have a higher acceptance amongst parents.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Sep 11, 2014

BioSpace

Internal Memo Reveals Johnson & Johnson Will Be Trimming Pension Benefits For New Hires

In its latest step to cut costs, Johnson & Johnson JNJ -0.42% will reduce pension benefits that are offered to employees who are hired - or rehired - after Jan. 1, according to an internal memo. The changes, which do not apply to existing employees or retirees, were not detailed, but reflect the way the "benefit landscape has continued to evolve in recent years," as well as "emerging trends" in employee career patterns and practices at competitors, writes Peter Fasolo, the J&J JJSF +0.48% worldwide vice president for human resources.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, J and J Snack Foods, Food

Courier News

Expanded Rutgers career fair offers more opportunitiesExpanded...

Expanded Rutgers career fair offers more opportunities Rutgers Career Services' Career & Intership Mega Fair has expanded to two days with a record 300 employers. Check out this story on mycentraljersey.com: http://mycj.co/1tDnojO Rutgers students and alumni recommended that their peers attend the university's expanded Career & Internship Mega Fair, which continues Friday on the Busch Campus.

Comment?

Related Topix: Rutgers University, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Scios, OrthoClinical Diagnostics, Medical Equipment

PR-inside.com

New Report Available: Janssen Research & Development, LLC -...

Janssen Research & Development , a subsidiary of Johnson and Johnson is a pharmaceutical company. The company discovers and develops innovative medicines that ease patients suffering and solve most important unmet medical needs.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, VisionCare Ophthalmic Technologies, Startups

The Motley Fool

Why Gilead Sciences Stock Is Up 40% in 2014

Shares in the company's stock have returned 40% this year, outpacing both the S&P 500 index's 10% return and the Nasdaq Biotechnology index's 19% return. That's an impressive performance, particularly for a company boasting a market cap of over $160 billion.

Comment?

Related Topix: Biotech, Science / Technology, Johnson & Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Lymphoma, Health, Leukemia

AmericanBankingNews.com

Stock Traders Purchase High Volume of Johnson & Johnson Call Options

Johnson & Johnson was the target of unusually large options trading on Wednesday. Investors purchased 16,917 call options on the stock, Analyst Ratings Net reports.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

BioSpace

Pfizer And Merck & Co. Execs Exclusive: Inside Tips For Getting Hired

September 11, 2014 By Mark Terry , BioSpace.com Breaking News Staff What to know what's hot in hiring trends for the world's 10 largest pharmaceutical companies, including Johnson & Johnson , Pfizer , Novartis , Merck & Co. , GlaxoSmithKline , Roche and AstraZeneca ? Then check out our guide.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Startups, BioSpace.com, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••